Korsana Biosciences, Inc.

Healthcare · Medical - Pharmaceuticals · United States

Last price 30.22 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.38B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases. The company has developed Therapeutic Targeting (THETA), a blood-brain barrier-penetrant shuttle platform designed to enhance central nervous system exposure of investigational therapies and enable delivery of large therapeutic molecules across the blood-brain barrier into the central nervous system. The company advances a pipeline of THETA-enabled therapeutics with an initial focus on neurodegenerative disorders. Its lead product candidat...